Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai United Imaging Healthcare CoSHSE:688271 -1.21%85 Return-on-Tangible-Equity is 8.08% as of Mar. 2026, which is 24% below its 10-year median of 10.63. GuruFocus rates SHSE:688271 with a GF Score™ of 85/100 and a GF Value™ of ¥175.31 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Shanghai United Imaging Healthcare Co ranks better than 65.88% on this metric.
The historical rank and industry rank for Shanghai United Imaging Healthcare Co's Return-on-Tangible-Equity or its related term are showing as below:
SHSE:688271'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -6.99 Med: 10.63 Max: 38.69
Current: 9.85
During the past 8 years, Shanghai United Imaging Healthcare Co's highest Return-on-Tangible-Equity was 38.69%. The lowest was -6.99%. And the median was 10.63%.
SHSE:688271's Return-on-Tangible-Equity is ranked better than 65.88% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.04
vs SHSE:688271: 9.85
Shanghai United Imaging Healthcare Co (SHSE:688271) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Shanghai United Imaging Healthcare Co Return-on-Tangible-Equity Related Terms
Shanghai United Imaging Healthcare Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai United Imaging Healthcare Co Return-on-Tangible-Equity Chart
SHSE:688271 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Shanghai United Imaging Healthcare Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai United Imaging Healthcare Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai United Imaging Healthcare Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Shanghai United Imaging Healthcare Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 8.08% mean?
Shanghai United Imaging Healthcare Co (SHSE:688271) has a Return-on-Tangible-Equity of 8.08% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Shanghai United Imaging Healthcare Co and its competitors. This is 24% below median its historical median of 10.63. According to the industry distribution chart, Shanghai United Imaging Healthcare Co ranks #259 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 34.1%.
Is Shanghai United Imaging Healthcare Co's Return-on-Tangible-Equity too high?
Shanghai United Imaging Healthcare Co's current Return-on-Tangible-Equity of 8.08% is 24% below median its 10-year median of 10.63. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.04. Shanghai United Imaging Healthcare Co's value of 8.08% is 100% above this industry median. Based on the distribution chart, Shanghai United Imaging Healthcare Co ranks #259 out of 759 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai United Imaging Healthcare Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai United Imaging Healthcare Co's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai United Imaging Healthcare Co ranks #259 out of 759 companies for Return-on-Tangible-Equity. This puts Shanghai United Imaging Healthcare Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.04. Shanghai United Imaging Healthcare Co's value of 8.08% is 100% above this benchmark. While the company's 10-year median is 10.63 vs. the industry median of 4.04, Shanghai United Imaging Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.04, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai United Imaging Healthcare Co's current Return-on-Tangible-Equity of 8.08% is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Shanghai United Imaging Healthcare Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai United Imaging Healthcare Co's current Return-on-Tangible-Equity is 8.08%, which is 24% below median its own 10-year median of 10.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai United Imaging Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai United Imaging Healthcare Co (SHSE:688271) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥175.31, compared to a current price of ¥110.37 — trading 37% below its estimated fair value. The current Return-on-Tangible-Equity is 8.08%, which is 24% below median its 10-year median of 10.63 and 100% above the Medical Devices & Instruments industry median of 4.04. Shanghai United Imaging Healthcare Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Shanghai United Imaging Healthcare Co (SHSE:688271), the current Return-on-Tangible-Equity is 8.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai United Imaging Healthcare Co (SHSE:688271) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai United Imaging Healthcare Co stock appears to be undervalued.
The current stock price of ¥110.37 is trading 37% below its estimated GF Value™ of ¥175.31.
GuruFocus considers Shanghai United Imaging Healthcare Co to be Significantly Undervalued.
Key valuation signals for SHSE:688271:
Return-on-Tangible-Equity: 8.08% (24% below median its 10-year median of 10.63)
GF Value™: ¥175.31 vs. price of ¥110.37 (37% below fair value)
Industry Position: 100% above the Medical Devices & Instruments median (#259 of 759)
No single metric tells the full story. See the SHSE:688271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai United Imaging Healthcare Co Business Description
Shanghai United Imaging Healthcare Co Ltd provides customers with high-performance medical imaging equipment, radiotherapy products, life science instruments, and medical digitalization and intelligent solutions. The company's products include MRI systems, CT scanners, X-ray imaging equipment, molecular imaging systems, radiotherapy linear accelerators, and life science instruments.
85GF Score
Get the complete analysis for SHSE:688271
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688271 has been successfully added to your 
